Immuno & Gene Therapy Committee

 Charter

 The Immuno & Gene Therapy Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the dendritic cell and immunotherapy category.
  • Review the status of the immuno & gene therapy field and compile a list of major scientific issues that must be addressed to advance or enable cellular therapies utilizing immunotherapy and gene therapy.
  • Publish position papers and engage in scientific discourse as necessary to advance the field.

 


Committee Members:



Kenneth Micklethwaite, MD
Co-Chair (Jan 2018 – Dec 2018)
The Westmead Institute for Medical Research
Sydney, Australia
Patrick Hanley, PhD
Co-Chair (Jan 2018 – Dec 2018)
Children's National Medical Center
Washington, DC, United States

 

 

Lisa Butterfield, PhD
Parker Institute for Cancer Immunotherapy
San Francisco, CA, United States
Bruce Levine, PhD
University of Pennsylvania
Philadelphia, PA, United States
   
Michaela Sharpe, PhD
Cell and Gene Therapy Catapult
London, United Kingdom
Mitchell Cairo, MD
New York Medical College
New York, NY, United States
   
Sandeep Soni, MD 
Stanford University
Stanford, CA, United States
Wei Dong Han, MD
Chinese PLA General Hospital
Beijing, China
   
David Gottlieb, MBBS, FRACP, FRCPA, MD
Westmead Hospital
Sydney, NSW, Australia
Donald Kohn, MD
University of California
Los Angeles, CA, United States
   
Jaap Jan Boelens, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, United States
Sung-Yun Pai, MD
Boston Children's Hospital
Boston, MA, United States
   

Andrew Fesnak, MD

University of Pennsylvania

Philadelphia, PA, United States

Cameron Turtle, MBBS, PhD, FRACP, FRCPA

Fred Hutchinson Cancer Research Center

Seattle, WA, United States

   
Alexey Bersenev, MD, PhD

Yale University

New Haven, CT, United States

Michael Gustafson, PhD

Mayo Clinic Arizona

Phoenix, AZ, United States

 

© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy